PARTNERS/FELLOWS

The BMG team of senior practitioners brings operational experience in both the corporate and the startup worlds

Heidi Mason <br/>Co-Founder and Managing Partner
Heidi Mason
Co-Founder and Managing Partner

Heidi Mason has spent more than twenty-five years in Silicon Valley, immersed in its ecosystem and venture-backed start-up community, as an entrepreneur focusing on start-up development and corporate venturing (CV) consulting.

In 1990, she cofounded the Bell Mason Group, a specialty management consultancy dedicated to improving corporate venture program development and impact. Mason developed the corporate venturing framework and assessment methodology that serves as a foundation for much of the Bell Mason Group work.

BMG clients have spanned the globe, across industry sectors, including Citigroup, Merck, Chevron, Philips, and Coca Cola. She has held numerous venture board seats over the years, along with strategic advisory board roles with large, global companies. Under her leadership, BMG has partnered with a variety of leading CV specialty service providers to accelerate quality CV program and platform development (in legal, compensation, innovation strategy, and accounting/tax). She has also been instrumental in guiding industry research and standards development that support CV practice professionalization and quality repeatability.

She became a Strategic Advisory Board member for Global Corporate Venturing shortly after its founding in 2010. She is also a multi-published author including co-authoring The Venture Imperative: A New Model of Corporate Innovation, Harvard Business School Press, and is a co-author of Corporate Venturing: A Survival Guide released January 2019

Mason holds a degree from the University of Pennsylvania, where she graduated with honors.

Liz Arrington <br/>Partner
Liz Arrington
Partner

Liz Arrington has spent decades advising global corporations on the development of best-practice venturing and innovation programs, with emphasis on performance management strategies and systems. She also collaborates with leading industry organizations such as Health Evolution Summit, J Thelander, and Global Corporate Venturing to develop specialist CV content and professional programs. She has worked extensively with venture-capital-backed start-ups around the globe to address nascent market development opportunities.

Ms. Arrington began her corporate venturing career with Mitsubishi International Corporation, in Silicon Valley, where she and Mason were first introduced. She subsequently spent eight years in Asia, where she cofounded the Asia-Pacific practice of VIA international, a global “routes to market” consultancy, and pioneered the firm’s venturing advisory practice. Shortly thereafter, she joined forces with BMG and spearheaded its successful introduction into ASEAN, North Asia, Australia, and New Zealand. Arrington relocated to Silicon Valley in 2001.

Ms. Arrington is a director of Tack Gives Back, a nonprofit supporting equine- and other animal-facilitated therapy organizations. She holds an MBA in marketing and finance from the Wharton School of the University of Pennsylvania, and an honors undergraduate degree from Harvard College.

Ms. Arrington is a multi-published author, most recently the co-author of Corporate Venturing: A Survival Guide released January 2019. She holds an MBA in marketing and finance from the Wharton School of the University of Pennsylvania, and an honors undergraduate degree from Harvard College.

FELLOWS

Gordon Bell <br/>Co-founder, Chair of Bell Mason Group
Gordon Bell
Co-founder, Chair of Bell Mason Group

Mr. Bell has been a principal researcher with Microsoft Research in San Francisco, California since 1995. At Microsoft, he is researching the capture and storage of everything an individual has experienced in his lifetime.

His previous roles include vice president of research and development at Digital Equipment Corp. (1960-1983); professor of computer science and electrical engineering at Carnegie-Mellon University (1966-72); founding assistant director of the National Science Foundation's Computing and Information Sciences and Engineering (CISE) Directorate (1986-1988); panel chair of the National Research and Education Network (NREN) for creating the Internet (1987-1988); advisor/investor in 100 plus start-up companies; and a founding trustee of the Computer History Museum in Mountain View, California.

Patty Burke <br/>Bell Mason Fellow
Patty Burke
Bell Mason Fellow

Patty Burke is a Venture and Innovation Catalyst responsible for commercializing innovation products and services and sourcing innovations to incorporate into the non-profit Center for Creative Leadership (CCL) product line. She also represents CCL in the Silicon Valley and Bay Area, working closely with clients in technology, healthcare and financial services. CCL is a global leader in research and executive education solely focused on leadership development.

Previously, Patty was founder and managing partner of Accelevate, an innovation consulting firm providing business model validation and innovation training for corporate innovation teams, based on Lean Startup and Business Model Canvas principles. Prior to co-founding Accelevate, Ms. Burke was a Bell Mason Group partner bringing a specialist venture perspective to BMG’s corporate venturing and innovation portfolio for global 1000 companies. Before that she led Burke Venture Consulting, working with venture capital firms and their portfolio companies on business planning, product and market strategies.

Ms. Burke also held executive positions with Silicon Valley software and networking companies for more than fifteen years. She was VP Marketing at Ramp Networks and at Madge Networks, guiding both companies through significant growth phases and IPOs. Prior to that Ms. Burke was VP Marketing at security software leader Symantec and Director of Product Marketing for the Peter Norton Product Group. Ms. Burke was also a partner with Regis McKenna Inc., and worked in consumer and sports marketing in her early career.

Patty is a member of the advisory board for the Global Corporate Venturing and Innovation Summit and is a Catalyst Award Advisor for the UCSF Clinical and Translational Science Institute. She is also a mentor and advisor to entrepreneurial programs at California College of the Arts/Design MBA and San Jose State University Lucas College and Graduate School of Business. She is a graduate of the University of Texas at Austin.

Larry Downes <br/>Bell Mason Fellow
Larry Downes
Bell Mason Fellow

Larry Downes is an Internet industry analyst and best-selling author on developing business strategies in an age of accelerating technological disruption.

He is the co-author, with Paul F. Nunes, of Big Bang Disruption: Strategy in the Age of Devastating Innovation (Portfolio 2014), now a bestseller. Based on extensive research, the book describes a new kind of disruptive innovation and teaches executives across industries how to adjust their strategies to survive it.

His previous book, The Laws of Disruption: Harnessing the New Forces that Govern Business and Life in the Digital Age explored the accident-prone intersection of law and innovation.

Downes is the author of the New York Times and Business Week best-seller, Unleashing the Killer App: Digital Strategies for Market Dominance, which was named by The Wall Street Journal as one of the five most important books ever published on business and technology.

He writes regularly for Forbes, Harvard Business Review, The Washington Post and CNET, and is frequently quoted in media stories in both mainstream and trade outlets.

He is currently Project Director at the Georgetown Center for Business and Public Policy and a Research Fellow with the Accenture Institute for High Performance.

He has previously held faculty appointments at the University of Chicago Booth School of Business, Northwestern University School of Law, and the University of California-Berkeley’s Haas School of Business, where he was Associate Dean of the School of Information. > Contact

Mark Klopp <br/>Bell Mason Fellow
Mark Klopp
Bell Mason Fellow

As a BMG fellow, Mr. Klopp contributes his extensive hands-on corporate venturing expertise, particularly in venture capital and medical technology. Mark is also an independent consultant, board member, advisor and investor. He is a Managing Director with Coronis Medical Ventures, an accelerator for medical devices. He assists Xinova in the area of licensing intellectual property for development and commercialization and is a business advisor for Larta and Tech Futures Group. Mark serves as a board member and business advisor for several private ventures and Christian ministries.

Mark is a former Board Member of the National Venture Capital Association (NVCA) and served as Chairman and founding member of the Corporate Venture Group. Formerly Managing Director of Eastman Ventures, Eastman Chemical Company's corporate venture capital arm, Mark started up and led the company's efforts to invest in and partner with private companies. He and his team forged relationships and co-investments with premier venture capitalists and corporations. Eastman invested with a top-quartile IRR track record in 25 ventures and 5 venture funds spanning Information Technology, Life Sciences, Advanced Materials and Clean Technology.

Mark developed extensive operating experience in international business management, sales and marketing while with Eastman. Previous assignments included: Assistant to the CEO and Chairman; Regional Business Manager for Europe, Middle East and Africa and several Marketing and Sales executive positions.

Mark earned a bachelor's degree in Chemical Engineering from Virginia Tech and an MBA in Management from Roosevelt University.

Paul McManus<br/>Bell Mason Fellow
Paul McManus
Bell Mason Fellow

Paul McManus is an Executive-in-Residence and Lecturer in the Department of Strategy and Innovation in the School of Management at Boston University. An award-winning member of the faculty, Mr. McManus teaches in the undergraduate and graduate programs, as well as at the executive level. For executive programs and his external consulting, he specializes in innovation processes that: uncover emergent high-growth opportunities, systematize the venturing process, and create novel platforms for the deployment of new products, services, and businesses. His current interests relate to the commercialization of deep science and formation public/private partnerships for funding R&D/new venture development. Additionally, McManus holds an administrative appointment to lead the development of the newly created initiative focused on “The Next Economy.”

Prior to joining the faculty at Boston University full-time in 2006, McManus spent six years sourcing deals, conducting due diligence and building startup teams with Boston Millennia Partners, a $740M early-stage venture capital fund based in Boston.

Previously, Mr. McManus spent eight years as a venture development consultant to technology startups, venture investors and multinational corporations across North America, Western/Central/Eastern Europe, Eurasia and MENA. During the first fifteen years of his career, he served as an engineer, product manager and new venture development executive with Digital Equipment Corporation.

Mr. McManus received his MBA from Boston University and his B.S. in Mechanical Engineering Technology from Wentworth Institute of Technology.

Lesley Pickford <br> Bell Mason Fellow
Lesley Pickford
Bell Mason Fellow

Lesley Pickford is a Bell Mason Fellow who brings over 20 years of domain experience in the building of biopharmaceutical startups and businesses, both venture capital and big Pharma backed.

She has held responsibilities in translational through Phase 3 clinical stage R&D, primarily in the areas of neurology, but also oncology and autoimmune disease indications. She also has experience with global Pharma partnered programs and has provided extensive CI, business development and alliance support in this context.

Her accomplishments include authoring nonclinical sections of over 25 INDs/CTAs and several successful NDAs/MAAs for currently approved drugs in neurology, pain and dermatology. Inventor on 19 US, plus worldwide, patent applications, with over 40 publications, abstracts, and presentations.

Lesley, currently a Senior Partner and Principal Analyst in the BioPharmaceutical practice at Oceana Associates, has held positions of increasing functional operational and scientific R&D leadership, through executive management levels, up to SVP Drug Development.

Lesley's education included a BSc (first class honors); a PhD in Medical Biochemistry; Postdoctoral Fellowships at the Stanford University School of Medicine in the Departments of Pathology and Psychiatry & Behavioral Sciences; and an Executive MBA at Santa Clara University.

John Zicker <br/>Bell Mason Fellow
John Zicker
Bell Mason Fellow

John Zicker is CEO at Amplion Inc, a startup which applies predictive analytics to life science challenges (Precision Medicine). As a Bell Mason Fellow, John provides specialist insights BMG corporate venturing & innovation clients that are exploring disruptive business models.

Previously he was COO at Vree Health acquired by PatientSafe and a five-time entrepreneur in the software fields of business intelligence, security and crowd sourced marketplaces. All five companies either went public or were acquired by larger corporations.

John was CEO of CrossLoop is an online marketplace for technical professionals to provide remote support to consumers and small businesses. CrossLoop was acquired in 2011. As CEO at Sana Security, Zicker transformed an interesting laboratory project into a thriving business that was successfully sold to AVG.

He co-founded and served as CTO of Sagent Technology a business intelligence company providing data-mart building, reporting and analytical tools His leadership contributed to an extremely successful initial public offering and a market capitalization in excess of $1 billion.

At ReportSmith, a company he co-founded in 1991, Zicker pioneered the world's first 'live' database reporting concept, acquiring enough customers and revenues to sell the company to Borland for six times its revenues.

Zicker has also held research positions at Stanford Linear Accelerator Center, NASA Ames and Lawrence Livermore Laboratories. Zicker holds an MSEE degree from the University of Wisconsin Madison and a BSEE degree from the University of California, Davis.